The Affordable Care Act (aka the ACA or Obama Care) goes into effect 8/1/2013) and more specifically in its attempt to tackle the 21st century obesity epidemic the new legislation requires employers to identify obesity in the workplace by using Body Mass Index (BMI), and to take actions designed to reduce obesity by enco
uraging (providing incentives for) employees to reduce their respective BMI scores.
That is an interesting article, first insurance must cover and now EMPLOYERS must help in treatment of OBESE people.
VBLOC device gets rid of obesity over time.....
I was surfing the internet and found an interesting article which states that under OBAMACARE insurance companies have to cover OBESITY so you can bet the farm that VBLOC will be in great demand which will halt this very expensive coverage due to an assortment of related problems that occur due to obesity. Article is current. Too long to post.
Here is the link:
Really, and did you tell them that you are a wolf in sheep's clothing, that you are a PAID BASHER hired by a Hedge Fund who is loading up and, that you are ripping innocent people off by making them sell their shares into institutions, to miss out on a rally and some money they may need in the future. Do you feel good doing Satan's work.
I made you an OFFER before, divulge me your name and phone number plus name and phone number where you worked, your schooling records and affidavit you are not a PAID BASHER.
As usual, the COWARD you are, you are going to ignore my OFFER.
Is 110 million OBESE USA Citizens big enough of a market for VBLOC at $ 10,000 per device meaning total market potential if they get 100% is $ 1,100,000,000,000.
Today, a third of Americans are obese, and two-thirds are overweight -- a distressing reality for many reasons. Obesity increases the risk of heart disease, stroke, cancer, and diabetes, all leading causes of death in the United States. Managing the complications of obesity is also extremely expensive. According to the Centers for Disease Control (CDC), obesity accounted for an estimated $147 billion, or 10 percent of the nation's medical costs, in 2008. More recent estimates suggest that annual obesity-related spending could be upwards of $200 billion.
Most efforts to address America's obesity epidemic have emphasized lifestyle changes: better eating habits, more physical activity. First Lady Michelle Obama has introduced a nationwide campaign against childhood obesity. Some states have begun requiring restaurants to post nutritional information (PDF) on their menus. Hospitals, insurance companies, and employers alike have implemented wellness programs that offer education and support.
For those already afflicted by obesity, however, behavioral adjustments alone may not cut it. In a study recently published in the New England Journal of Medicine, patients with obesity were given "lifestyle coaches" to help them lose weight. The result? After working closely with their coaches for two years, patients lost on average five percent of their body weight. But there were no significant changes in blood pressure, blood sugar levels, or cholesterol levels to suggest a change in the risk of obesity-related disease or death. The patients may have looked a few pounds lighter, but they didn't appear much healthier.
ETRM met FDA in May
2013 and showed them their 12th month data. ETRM asked if data was strong enough for approval. ETRM encouraged ETRM to file PMA which they did in June 2013 and was quickly accepted by FDA for review. FDA came back in September 2013 wanting additional information with relating mainly to training of personnel on device and ensuring its function. This sounded alot like we are going to approve and just to make sure sales staff has competence. FDA requested that ETRM give them 18th month data which would beef up the clinical results showing long term benefits, which it did. FDA now working to schedule Fed panel of Doctors in 1st quarter 2014. The FDA guidelines stipulate that they will approve a device or pill in the obesity market if the safety and benefit outweigh risks, which it does here 24.5% EWL, statistical significance over placebo and hypertension and diebetic benefits.
ETRM will expand the VBLOC device to the diebetic and hypertension market which is absolutely HUGE and which is a big step ahead of obesity pills which have no such benefit.
In numbers, we are talking about $ 1 billion per year in revenue from obesity, with miniscule market share and, surely another $ 1 billion for diebetic and hypertension market.
Insurance companies will flock to this VBLOC device which will become standard since it will bring down insurance costs and the $ 147 billion in Obamacare per year costs to treat FAT people.
Top again, I asked oozhe22 to give me his name and phone number plus the names and phones of places he worked, his schooling records, his disclosure as to whether he worked or not at ETRM and sworn affidavit he is not a PAID BASHER. To date all I got was blah blah blah....so there you have it, he is totally baloney. Careful as he tries to steal your shares.
See how you are a COWARD, me too I am make a list and refer you to a website. I want your name, phone number, names of institutions you worked at with phone number, a copy of your resume showing your history, a photo of your drivers permit, a copy of your schooling records, a disclosure as to whether you worked or ever invested in ETRM, a sworn affidavit that you are not a PAID BASHER, etc...
I will give all of this to my lawyer who will check you out plus your allegations.
To date, all I got was more talk, predictable of a COWARD